Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Cancer Biologics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Cancer Biologicsmarket, defines the market attractiveness level of Cancer Biologics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Cancer Biologics industry, describes the types of Cancer Biologics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cancer Biologics market and the development prospects and opportunities of Cancer Biologics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cancer Biologics market in Chapter 13.
By Player:
Celgene
Merck
Novartis
Bristol-Myers Squibb
Johnson & Johnson
Eli Lilly
Sanofi
Bayer
Roche
Amgen
Pfizer
By Type:
Monoclonal Antibodies
Vaccines
Cell and Gene Therapy
Others
By End-User:
Hospitals
Clinics
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Cancer Biologics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Cancer Biologics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Cancer Biologics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Cancer Biologics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Cancer Biologics Market Analysis and Outlook to 2022
-
7.1 Global Cancer Biologics Consumption (2017-2022)
-
7.2 United States Cancer Biologics Consumption (2017-2022)
-
7.3 Europe Cancer Biologics Consumption (2017-2022)
-
7.4 China Cancer Biologics Consumption (2017-2022)
-
7.5 Japan Cancer Biologics Consumption (2017-2022)
-
7.6 India Cancer Biologics Consumption (2017-2022)
-
7.7 South Korea Cancer Biologics Consumption (2017-2022)
8 Region and Country-wise Cancer Biologics Market Analysis and Outlook to 2028
-
8.1 Global Cancer Biologics Consumption Forecast (2022-2028)
-
8.2 United States Cancer Biologics Consumption Forecast (2022-2028)
-
8.3 Europe Cancer Biologics Consumption Forecast (2022-2028)
-
8.4 China Cancer Biologics Consumption Forecast (2022-2028)
-
8.5 Japan Cancer Biologics Consumption Forecast (2022-2028)
-
8.6 India Cancer Biologics Consumption Forecast (2022-2028)
-
8.7 South Korea Cancer Biologics Consumption Forecast (2022-2028)
9 Global Cancer Biologics Market Outlook by Types and Applications to 2022
-
9.1 Global Cancer Biologics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Vaccines Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Cell and Gene Therapy Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Cancer Biologics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Cancer Biologics Market Outlook by Types and Applications to 2028
-
10.1 Global Cancer Biologics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Cell and Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Cancer Biologics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Cancer Biologics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Cancer Biologics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Cancer Biologics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Cancer Biologics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Cancer Biologics Market Competitive Analysis
-
14.1 Celgene
-
14.1.1 Celgene Company Details
-
14.1.2 Celgene Cancer Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Celgene Cancer Biologics Product and Service
-
14.2 Merck
-
14.2.1 Merck Company Details
-
14.2.2 Merck Cancer Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Merck Cancer Biologics Product and Service
-
14.3 Novartis
-
14.3.1 Novartis Company Details
-
14.3.2 Novartis Cancer Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novartis Cancer Biologics Product and Service
-
14.4 Bristol-Myers Squibb
-
14.4.1 Bristol-Myers Squibb Company Details
-
14.4.2 Bristol-Myers Squibb Cancer Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Bristol-Myers Squibb Cancer Biologics Product and Service
-
14.5 Johnson & Johnson
-
14.5.1 Johnson & Johnson Company Details
-
14.5.2 Johnson & Johnson Cancer Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Johnson & Johnson Cancer Biologics Product and Service
-
14.6 Eli Lilly
-
14.6.1 Eli Lilly Company Details
-
14.6.2 Eli Lilly Cancer Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Eli Lilly Cancer Biologics Product and Service
-
14.7 Sanofi
-
14.7.1 Sanofi Company Details
-
14.7.2 Sanofi Cancer Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Sanofi Cancer Biologics Product and Service
-
14.8 Bayer
-
14.8.1 Bayer Company Details
-
14.8.2 Bayer Cancer Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Bayer Cancer Biologics Product and Service
-
14.9 Roche
-
14.9.1 Roche Company Details
-
14.9.2 Roche Cancer Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Roche Cancer Biologics Product and Service
-
14.10 Amgen
-
14.10.1 Amgen Company Details
-
14.10.2 Amgen Cancer Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Amgen Cancer Biologics Product and Service
-
14.11 Pfizer
-
14.11.1 Pfizer Company Details
-
14.11.2 Pfizer Cancer Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Pfizer Cancer Biologics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Cancer Biologics
-
Figure Cancer Biologics Picture
-
Table Global Cancer Biologics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cancer Biologics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cancer Biologics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Cancer Biologics Consumption by Country (2017-2022)
-
Figure United States Cancer Biologics Consumption and Growth Rate (2017-2022)
-
Table Europe Cancer Biologics Consumption and Growth Rate (2017-2022)
-
Figure China Cancer Biologics Consumption and Growth Rate (2017-2022)
-
Figure Japan Cancer Biologics Consumption and Growth Rate (2017-2022)
-
Figure India Cancer Biologics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Cancer Biologics Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Biologics Consumption Forecast by Country (2022-2028)
-
Figure United States Cancer Biologics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Cancer Biologics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Cancer Biologics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Cancer Biologics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Cancer Biologics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Cancer Biologics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Global Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Global Cell and Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cell and Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Cancer Biologics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Cancer Biologics Export by Region (Top 5 Countries) (2017-2028)
-
Table Celgene (Foundation Year, Company Profile and etc.)
-
Table Celgene Cancer Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Cancer Biologics Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Cancer Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Cancer Biologics Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Cancer Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Cancer Biologics Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Cancer Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Cancer Biologics Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Cancer Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Cancer Biologics Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Cancer Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Cancer Biologics Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Cancer Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Cancer Biologics Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Cancer Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Cancer Biologics Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Cancer Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Cancer Biologics Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Cancer Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Cancer Biologics Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Cancer Biologics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Cancer Biologics Product and Service
-
